We are live on ! Find out more
DARE icon

Dare Bioscience

36 hedge funds and large institutions have $3.35M invested in Dare Bioscience in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more capital inflows, than outflows

Capital inflows: $153K | Capital outflows: $55.3K

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

3% more funds holding

Funds holding: 35 → 36 (+1)

0.22% more ownership

Funds ownership: 6.7% → 6.92% (+0.22%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DARE Hedge Fund Activity: Q1 2024 in Review

36 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2024, worth a combined $3.35M — up 64% from $2.04M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DARE positions and 6 closed out — a net gain of 1 holder — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $65.8K. The largest seller was HighTower Advisors, cutting an estimated $14.7K.

  • 36 institutional investors held Dare Bioscience (DARE) as of Q1 2024, up from 35 in Q4 2023.
  • Funds reported $3.35M of Dare Bioscience stock for Q1 2024, up 64% quarter-over-quarter.
  • 7 funds opened new Dare Bioscience positions in Q1 2024 and 6 closed out, a net change of +1 holder.
  • The largest Dare Bioscience buyer in Q1 2024 was Citadel Advisors, an estimated $65.8K added.
  • The largest Dare Bioscience seller in Q1 2024 was HighTower Advisors, an estimated $14.7K sold.

Based on aggregated 13F filings for Q1 2024.